CliffBio
small molecule

DIHYDROERGOTAMINE MESYLATE

DIHYDROERGOTAMINE MESYLATE

Loss of exclusivity—loss of exclusivity
CompanyCipla →See this company's full patent-cliff portfolio

Drug detail

Brand nameDIHYDROERGOTAMINE MESYLATE
Active ingredientDIHYDROERGOTAMINE MESYLATE
Strength1MG/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalSeptember 2024
Marketing statusDISCN

More from Cipla

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

DIHYDROERGOTAMINE MESYLATE patent cliff — loss of exclusivity — | CliffBio